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Small polystyrene particles coated with a high A4, non-ionic surfactant (Poloxamer 338) are diverted from 
the reticuloendothelial system of the liver and spleen to other tissue sites. These results are discussed in 
terms of the adsorption of the Poloxamer to the particle surface and the implications for drug targeting. 
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1. INTRODUCTION 
Small colloidal particles such as liposomes, 
microspheres and nanoparticles have been sug- 
gested as possible carriers for the selective delivery 
of drugs to tissue sites in particular tumours [l-3]. 
However, the cells of the reticuloendothelial 
system in the liver and the spleen effectively 
remove the great majority of such particles [4,5]. 
As a consequence, attention is now being focussed 
on the use of colloidal particles for the passive 
delivery of drugs to the reticuloendothelial system 
itself, for example in the treatment of 
Leishmaniasis [6]. The uptake of particles by the 
reticuloendothelial system is normally very rapid 
but can be delayed, though not significantly 
altered, by surface coatings [7,8]. Particles can be 
diverted to other sites by blocking the reticuloen- 
dothelial system using excess of placebo colloid or 
by preinjection with, for example, dextran 
sulphate [9,10]. However, this approach would not 
be applicable in clinical practice. It is established 
that the physicochemical characteristics in par- 
ticular size, surface charge and surface 
hydrophobicity of the particles are important 
determinants in phagocytic uptake [ 11,121. 
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Therefore we have investigated in detail the col- 
loidal science aspects of surface coatings. We have 
predicted that the coating of a particle with a high 
M, non-ionic polymeric material, that would give 
rise to a hydrophilic surface with a low surface 
charge and the opportunity for steric stabilisation 
[ 13,141, should give rise to a minimum uptake by 
the reticuloendothelial system, thereby allowing 
particles to reach other sites. The polyoxy- 
ethylene-polyoxypropylene series of non-ionic 
surfactants were selected for examination. These 
have the correct physicochemical characteristics 
[ 151 and some have already been employed in phar- 
maceutical formulations administered intra- 
venously in man [ 16,171. They have also been used 
clinically in extracorporeal circulation systems 
[18]. It would seem that they have good biocom- 
patibility and low toxicity [ 191. 
2. EXPERIMENTAL 
Polystyrene microspheres in the size range 
50-60 nm were obtained from Polyscience (North- 
ampton) and surface labelled with 1311 as in [20]; 
lOO-120&i labelled material (0.5 ml = 2 x 10” 
nanoparticles) were administered to New Zealand 
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White rabbits (2.5 kg) via the marginal ear vein. 
The particles were suspended either in saline or in 
water containing 1% of, Poloxamer 338 or Polox- 
amer 188 (Ugine Kuhlmann, Bolton). The distribu- 
tion of the particles in various body organs was 
followed using external scintigraphic imaging [20]. 
Dynamic and static images were recorded at 
suitable times during an B-day period. Circulating 
activity in the blood was determined using a gam- 
ma probe technique [21]. After 8 days the animals 
were killed and the activity in various organs as 
well as the carcass was measured [20]. 
3. RESULTS 
Scintigraphic evaluation of the distribution of 
particles shows that he organ distribution of the 
polystyrene particles could be altered using a sur- 
face coating of Poloxamer 338 but not with Polox- 
amer 188 (fig.1). Uncoated particles and those 
coated with Poloxamer 188 were taken out of the 
circulation rapidly and were deposited mainly in 
the liver and spleen. Approximately 90% of the 
particles were deposited in these organs and the 
half time for clearance was of the order of 50 s. 
The amounts deposited in the heart and lungs as 
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Fig.1. Effect of coating on the distribution of 
polystyrene latex. Activity-time profiles for different 
body regions after administration of uncoated and 
Poloxamer 338-coated polystyrene latex particles 
(50 nm) (n = 3, mean f SE). Uncoated: liver/spleen (A); 
lung/heart (A); carcass/blood (v). Coated: liver/spleen 
(0); lung/heart (0); carcass/blood (0). 
Fig.2. Scintiscans of rabbits 3 h after intravenous administration of uncoated and Poloxamer 338~coated polystyrene 
particles (50 nm). (A) Uncoated; (B) Poloxamer 338-coated. 
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Fig.3. Distribution of uncoated and Poloxamer 188- and 
Poloxamer 338-coated polystyrene particles (50 nm) in 
various organs 8 days after intravenous administration 
(n = 3, mean + SE). 
well as the carcass and remaining in the blood, 
were negligible. In contrast, the particles coated 
with Poloxamer 338 showed a very different 
distribution pattern (fig. 1). Although some par- 
ticles were taken up rapidly by the liver and spleen 
the total quantity in these organs was greatly 
reduced. Higher activities were found in the lung 
and heart regions as well as in the carcass and 
blood. The measured profiles for blood clearance 
for the uncoated and the Poloxamer 188-coated 
systems were very different to that seen for the 
Poloxamer 338 system. For the last system sus- 
tained levels of activity were observed. These dif- 
ferences in distributions are clearly shown in the 
scintiphotos (fig.2a,b). The diversion of particles 
from the liver/spleen region to the bone marrow 
and soft tissue is apparent. 
The data for organ deposition for the 3 systems 
are shown in the form of a histogram (fig.3). 
Coating the particles with Poloxamer 188 gives rise 
to a significant increase in the number of particles 
reaching the lung but does not reduce significantly 
the liver and spleen uptakes. The particles coated 
with Poloxamer 338 have higher levels in the lungs, 
spleen and carcass and a corresponding reduction 
in the quantity reaching the liver. 
4. DISCUSSION 
Non-ionic surface active agents of the Polox- 
amer type are adsorbed strongly to the surface of 
colloidal particles. The polyoxypropylene group of 
the Poloxamer polymer functions as the anchoring 
moiety. The polyoxyethylene groups remain free in 
the external aqueous environment and can give rise 
to colloidal stability by a repulsion effect through 
a steric enthalpic-entropic mechanism of stabilisa- 
tion [13]. Poloxamer 188 has an average M, of 
8350 with an ethylene oxide building block of an 
average value (in mol) of 75, while Poloxamer 338 
has an average M, of 14000 and an ethylene oxide 
block of an average value (in mol) of 128. These 
differences in molecular characteristics can give 
rise to different adsorbed layer thicknesses of 
14 nm and 26 nm for 188 and 338, respectively 
[ 151, as well as differences in surface charge in the 
absence and presence of serum [14,22]. Thus it is 
to be expected that a colloidal particle coated with 
Poloxamer 338 will present a hydrophilic surface 
of high M, with a structure (loops and tails) that 
will give rise to good colloid stability and minimal 
adhesive properties [24]. The higher A4, Poloxamer 
(338) will be more effective in this respect han the 
low iV& Poloxamer (188). 
Authors in [14] have shown that the uptake of 
emulsion droplets coated with Poloxamers by 
mouse peritoneal macrophages and a soil amoeba 
species was dependent on the nature of the Polox- 
amer; Poloxamer 188-coated particles being 
cleared more rapidly than those coated with Polox- 
amer 338. In [23] a similar effect was demonstrated 
when studying the blood-clearance of emulsion 
systems administered intravenously to mice. 
We believe that the reduced uptake of the Polox- 
amer 338-coated particles in the liver and their 
diversion to other tissue sites is related directly to 
the physical properties of the adsorbed Poloxamer 
layer. It is known that the complement system is 
activated when it comes in contact with synthetic 
polymer surfaces and that certain complement 
components can be taken up rapidly [25]. Particles 
coated with complement will be cleared rapidly by 
the liver and spleen. The coating of the particles 
with Poloxamer 338 reduces or even eliminates the 
uptake of the opsonic material 1121 and the subse- 
quent phagocytic engulfment by the Kupffer cells 
is minimised [ 121. Poloxamer 338 is much more ef- 
fective in this respect, either because of its greater 
stabilising effect or its somewhat stronger binding 
to the surface of the particles. There is no evidence 
to suggest that Poloxamer can cause blockade of 
the reticuloendothelial system, indeed the quantity 
of Poloxamer administered (2 mg/kg) is but a 
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fraction of the quantity of other materials 
employed for this purpose (20 mg/kg) [lo]. 
Our results suggest that the judicious use of non- 
ionic surfactants can be exploited to direct in- 
travenously administered colloidal drug carrier 
particles away from the reticula-endothelial system 
so they are able to reach other target sites (e.g., 
tumour tissue). 
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